Accordingly, increased hepatic iron stores are observed in about half of adult NAFLD patients and may potentiate the onset and progression of disease by altering insulin signaling and metabolic function [2,67]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.